Ion Channels in Cancer-induced Bone Pain: from Molecular Mechanisms to Clinical Applications
Overview
Authors
Affiliations
Cancer-induced bone pain (CIBP) caused by bone metastasis is one of the most prevalent diseases, and current treatments rely primarily on opioids, which have significant side effects. However, recent developments in pharmaceutical science have identified several new mechanisms for CIBP, including the targeted modification of certain ion channels and receptors. Ion channels are transmembrane proteins, which are situated on biological cell membranes, which facilitate passive transport of inorganic ions across membranes. They are involved in various physiological processes, including transmission of pain signals in the nervous system. In recent years, there has been an increasing interest in the role of ion channels in chronic pain, including CIBP. Therefore, in this review, we summarize the current literature on ion channels, related receptors, and drugs and explore the mechanism of CIBP. Targeting ion channels and regulating their activity might be key to treating pain associated with bone cancer and offer new treatment avenues.
Chen Y, Li T Int J Mol Sci. 2025; 26(4).
PMID: 40004233 PMC: 11855056. DOI: 10.3390/ijms26041770.
Role of TRP Channels in Cancer-Induced Bone Pain.
Coluzzi F, Scerpa M, Alessandri E, Romualdi P, Rocco M Int J Mol Sci. 2025; 26(3).
PMID: 39940997 PMC: 11818569. DOI: 10.3390/ijms26031229.
Zhang Z, Tian Y, Li S, Jing H, Cai J, Li M Cell Commun Signal. 2024; 22(1):416.
PMID: 39192337 PMC: 11350972. DOI: 10.1186/s12964-024-01797-2.
Targeting TRPV4 Channels for Cancer Pain Relief.
Antoniazzi C, Andrighetto Ruviaro N, Peres D, Rodrigues P, Viero F, Trevisan G Cancers (Basel). 2024; 16(9).
PMID: 38730655 PMC: 11083562. DOI: 10.3390/cancers16091703.
Targeting TRPV1 for Cancer Pain Relief: Can It Work?.
Szallasi A Cancers (Basel). 2024; 16(3).
PMID: 38339399 PMC: 11154559. DOI: 10.3390/cancers16030648.